![Andre Tartar](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andre Tartar
Direttore/Membro del Consiglio presso GENOWAY
Profilo
Dr. Andre Tartar is a Professor at Université de Lille II.
He is on the Board of Directors at genOway SA. Dr. Tartar was previously employed as a Chemistry Director by Ferring Research Institute, Inc., a Chief Scientific Officer by Cerep SA, a Chairman-Bioorganic Chemistry Department by Institut Pasteur de Lille, a Principal by Diverchim SA, and a President by Société de Chimie Therapeutique.
He also served on the board at ORPHELIA Pharma SAS.
Posizioni attive di Andre Tartar
Società | Posizione | Inizio |
---|---|---|
GENOWAY | Direttore/Membro del Consiglio | - |
Université de Lille II | Corporate Officer/Principal | 01/01/1981 |
Precedenti posizioni note di Andre Tartar
Società | Posizione | Fine |
---|---|---|
Ferring Research Institute, Inc.
![]() Ferring Research Institute, Inc. Drugstore ChainsRetail Trade Ferring Research Institute, Inc. is a biopharmaceutical company, which engages in identifying, developing, and marketing of products. It focuses on the fields of endocrinology, gastroenterology, infertility, obstetrics, urology and osteoarthritis. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2004 |
EUROFINS CEREP | Fondatore | 01/01/1998 |
Institut Pasteur de Lille | Fondatore | 01/01/1996 |
Société de Chimie Therapeutique
![]() Société de Chimie Therapeutique Miscellaneous Commercial ServicesCommercial Services Société de Chimie Thérapeutique is a French Medchem Society based in Malabry, France. The society is administered by an Executive Board and provides for the re-election or replacement of its members through a call for nominations process. The society also supports young researchers by providing a prestigious prize entitled “Prix d’Encouragement à la Recherche en Chimie Thérapeutique” sponsored by Institut de Recherche Servier, which is devoted to junior European scientists. The society complies with the law of July 10, 2012, on various provisions relating to electronic communications and transposes the European Directive No. 2009/136/EC of the European Parliament and of the Council of November 25, 2009, regarding the new constraints and obligations of publishers and owners of websites on information. The call for 2023 Young Medicinal Chemist in Industry Award is now closed, and the new call will be announced in November 2023. | Presidente | - |
ORPHELIA Pharma SAS
![]() ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology ORPHELIA Pharma SA specializes on biopharmaceutical products improving the health and well being of severely disabled children. The company was founded by Hugues Bienaymé in 2007 and is headquartered in Paris, France. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
EUROFINS CEREP | Commercial Services |
GENOWAY | Health Technology |
Aziende private | 5 |
---|---|
Institut Pasteur de Lille | Commercial Services |
Ferring Research Institute, Inc.
![]() Ferring Research Institute, Inc. Drugstore ChainsRetail Trade Ferring Research Institute, Inc. is a biopharmaceutical company, which engages in identifying, developing, and marketing of products. It focuses on the fields of endocrinology, gastroenterology, infertility, obstetrics, urology and osteoarthritis. The company is headquartered in San Diego, CA. | Retail Trade |
Diverchim SA
![]() Diverchim SA Pharmaceuticals: MajorHealth Technology Diverchim SA provides pharmaceutical services. It offers computer aided drug, medicinal chemistry, immunochemistry, chemical development, analytical services, and discovery. The firm products are building blocks and screening, collection, and new tools for asymmetric catalysis. The company was founded by Jean Louis Brayer and Benoit Folleas in March 2001 and is headquartered in Roissy-en-France, France. | Health Technology |
ORPHELIA Pharma SAS
![]() ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology ORPHELIA Pharma SA specializes on biopharmaceutical products improving the health and well being of severely disabled children. The company was founded by Hugues Bienaymé in 2007 and is headquartered in Paris, France. | Health Technology |
Société de Chimie Therapeutique
![]() Société de Chimie Therapeutique Miscellaneous Commercial ServicesCommercial Services Société de Chimie Thérapeutique is a French Medchem Society based in Malabry, France. The society is administered by an Executive Board and provides for the re-election or replacement of its members through a call for nominations process. The society also supports young researchers by providing a prestigious prize entitled “Prix d’Encouragement à la Recherche en Chimie Thérapeutique” sponsored by Institut de Recherche Servier, which is devoted to junior European scientists. The society complies with the law of July 10, 2012, on various provisions relating to electronic communications and transposes the European Directive No. 2009/136/EC of the European Parliament and of the Council of November 25, 2009, regarding the new constraints and obligations of publishers and owners of websites on information. The call for 2023 Young Medicinal Chemist in Industry Award is now closed, and the new call will be announced in November 2023. | Commercial Services |
- Borsa valori
- Insiders
- Andre Tartar